Undetectable dystrophin can still result in a relatively benign phenotype of dystrophinopathy

Neuromuscular Disorders

Volumn 9, Issue 4, 1999, Pages 220-226

  Hattori, Noriaki ^a,b   Kaido, Misako ^b   Nishigaki, Toshinori ^b   Inui, Koji ^b   Fujimura, Harutoshi ^b   Nishimura, Tomoya ^a,b   Naka, Takashi ^a   Hazama, Takanori ^a  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

dystroglycan; Becker muscular dystrophy; Dystrophin; Utrophin

Indexed keywords

DYSTROGLYCAN; DYSTROPHIN; UTROPHIN;

ADULT; ARTICLE; BECKER MUSCULAR DYSTROPHY; CASE REPORT; CLINICAL FEATURE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE BIOPSY; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; DNA; DYSTROPHIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MYOCARDIUM; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0033065198     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(99)00005-X     Document Type: Article

References (25)

1. Koenig M., Hoffman E.P., Bertelson C.J., Monaco A.P., Feener C., Kunkel L.M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 50:1987;509-517.
2. D'Souza V.N., Nguyen T.M., Morris G.E., Karges W., Pillers D.M., Ray P.N. A novel dystrophin isoform is required for normal retinal electrophysiology. Hum Mol Genet. 4:1995;837-842.
3. Bushby K.M.D. The muscular dystrophies. Baillière's Clin Neurol. 3:1994;407-430.
4. Ozawa E., Yoshida M., Suzuki A., Mizuno Y., Hagiwara Y., Noguchi S. Dystrophin-associated proteins in muscular dystrophy. Hum Mol Genet. 4:1995;1711-1716.
5. Emery A.E.H., Skinner R. Clinical studies in benign (Becker type) X-linked muscular dystrophy. Clin Genet. 10:1976;189-201.
6. Mizuno Y., Nonaka I., Hirai S., Ozawa E. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects. J Neurol Sci. 119:1993;43-52.
7. Vainzof M., Passos-Bueno M.R., Nguyen T.M., Zatz M. Absence of correlation between utrophin localization and quantity and the clinical severity in Duchenne/Becker dystrophies. Am J Med Genet. 58:1995;305-309.
8. Bar S., Barnea E., Levy Z., Neuman S., Yaffe D., Nudel U. A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution. Biochem J. 272:1990;557-560.
9. Lederfein D., Levy Z., Augier N.et al. A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other non-muscle tissues. Proc Natl Acad Sci USA. 89:1992;5346-5350.
10. Chamberlain JS, Gibbs RA, Ranier JE, Caskey CT. Multiplex PCR for the diagnosis of Duchenne muscular dystrophy. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications, New York: Academic Press, 1990:272-281.
11. Beggs A.H., Koenig M., Boyce F.M., Kunkel L.M. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet. 86:1990;45-48.
12. Gangopadhyay S.B., Sherratt T.G., Heckmatt J.Z.et al. Dystrophin in frameshift deletion patients with Becker muscular dystrophy. Am J Hum Genet. 51:1992;562-570.
13. Koenig M., Beggs A.H., Moyer M.et al. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet. 45:1989;498-506.
14. Morrone A., Zammarchi E., Scacheri P.C.et al. Asymptomatic dystrophinopathy. Am J Med Genet. 69:1997;261-267.
15. Monaco A.P., Bertelson C.J., Liechti-Gallati S., Moser H., Kunkel L.M. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 2:1988;90-95.
16. Malhotra S.B., Hart K.A., Klamut H.J.et al. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science. 242:1988;755-759.
17. Winnard A.V., Klein C.J., Coovert D.D.et al. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. Hum Mol Genet. 6:1993;737-744.
18. Winnard A.V., Mendell J.R., Prior T.W., Florence J., Burghes A.H.M. Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production. Am J Hum Genet. 56:1995;158-166.
19. Deconinck A.E., Rafael J.A., Skinner J.A.et al. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell. 90:1997;717-727.
20. Arahata K., Ishiura S., Ishiguro T.et al. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature. 333:1988;861-863.
21. Maeda M., Nakao S., Miyazato H.et al. Cardiac dystrophin abnormalities in Becker muscular dystrophy assessed by endomyocardial biopsy. Am Heart J. 129:1995;702-707.
22. Ohlendieck K., Matsumura K., Ionasescu V.V.et al. Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma. Neurology. 43:1993;795-800.
23. Hoffman E.P., Fischbeck K.H., Brown R.H.et al. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med. 318:1988;1363-1368.
24. Patel K., Leevers S., Abbs S.et al. Absence of dystrophin in Becker muscular dystrophy. Lancet. i:1989;47.
25. Mongini T., Palmucci L., Doriguzzi C., Chiadò-Piat L., Restagno G. Absence of dystrophin in two patients with Becker type Xp21 muscular dystrophy. Neurosci Lett. 147:1992;37-40.